Optimizing (O) rifapentine-based (RI) regimen and shortening (EN) the treatment of drug-susceptible tuberculosis (T) (ORIENT) using an adaptive seamless design: study protocol of a multicenter randomized controlled trial

BACKGROUND: Standard treatment for drug-susceptible tuberculosis (DS-TB) includes a multidrug regimen requiring at least 6 months of treatment, and this lengthy treatment easily leads to poor adherence. There is an urgent need to simplify and shorten treatment regimens to reduce interruption and adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Zhen, Miao, Yan, Peng, Ying, Sun, Feng, Zhang, Yilin, Li, Rong, Ge, Shijia, Chen, Xinchang, Song, Lingyun, Li, Yang, Wang, Xiaomeng, Zhang, Wenhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165810/
https://www.ncbi.nlm.nih.gov/pubmed/37158831
http://dx.doi.org/10.1186/s12879-023-08264-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165810/
https://www.ncbi.nlm.nih.gov/pubmed/37158831
http://dx.doi.org/10.1186/s12879-023-08264-2

Ejemplares similares